Language:      

Biomedicine through Apitherapy



TABLE OF CONTENTS:

Instead of introduction: an anniversary e-mail, signal of overviews
Chapter .I. ON THE BEES WORLD
I.1.CURIOSITIES OF BEES LIFE
I.2.KNOWN AND UNKNOWN ABOUT BEE GIFTS
Chapter II. APITHERAPY AND APITHERAPEUTIST
II.1. APITHERAPY BETWEEN THEORY AND PRACTICE
II.2. THE APITHERAPEUTIST
Chapter III. CONTRIBUTIONS FOR DEVELOPING THE APITHERAPY
III.1. MASTERS, DOCTORATES AND POSTDOCTORAL STUDIES
III.2. EDUCATIONAL CONTRIBUTIONS
III.3. PUBLISHING CONTRIBUTIONS
III.3.1. PUBLISHED BOOKS
III.3.2. PUBLISHED STUDIES AND ARTICLES
Chapter 4. PRODUCTION OF HONEY BEE THERAPEUTIC PRODUCTS
IV.1. THE NEED OF HONEY BEE THERAPEUTIC PRODUCTS
IV.2. THE HERITAGE
IV.3. BIOCHEMISTRY OF HONEY BEE PRODUCTS, SUPPORT OF HONEY BEE THERAPEUTIC RODUCTS PRODUCED BY APITHERAPY MEDUCAL CENTER
IV.3.1.BEE PRODUCTS. THEIR QUICK LOOK
IV.3.1.1. HONEY
IV.3.1.2. ROYAL JELLY
IV.3.1.3. APILARNIL
IV.3.1.4. POLLEN
IV.3.1.5. BEE BREAD
IV.3.1.6. PROPOLIS
IV.3.1.7. WAX
IV.3.1.8. BEE VENOM
IV.4. HONEY BEE PHARMACY AND HUMAN CELL
IV.4.1.HONEY BEE BIOMOLECULES - HUMAN CORRESPONDENCE
IV.4.2. HONEY BEE THERAPEUTIC PRODUCTS, HUMAN CELL AND EXTRACELLULAR ENVIRONMENT
IV.5. CHARACTERISTICS OF HONEY BEE THERAPEUTIC PRODUCTS PRODUCED BY APITHERAPY MEDICAL CENTER
IV.5.1. BINOMIAL CHARACTER OF HONEY BEE THERAPEUTIC PRODUCTS
IV.5.2. THREE DIMENSIONAL NATURE OF HONEY BEE THERAPEUTIC PRODUCTS
IV.5.3. SYNERGISTIC NATURE OF HONEY BEE THERAPEUTIC PRODUCTS
IV.5.3.1. BIOCHEMICAL OFFER SYNERGY OF HONEY BEE THERAPEUTIC PRODUCTS
IV.5.3.2. CLINICAL ACTION SYNERGY THROUGH PRESENCE SYNERGY
IV.5.3.2.1. AN EXAMPLE OF CLINICAL SYNERGY IN AUTOIMMUNITY
IV.5.3.3. HONEY BEE THERAPEUTIC PRODUCTS AND HONEY BEE STEM CELLS
IV.5.4. HONEY BEE THERAPEUTIC PRODUCTS PRODUCED BY APITHERAPY MEDICAL CENTER
Chapter V. OUR METHOD IN APIPROPHYLAXIS AND APITHERAPY
V.1. HEALTH, DISEASE, DIAGNOSIS
V.1.1. CLASSIFYNG THE DISEASES
V.2. CLINICAL APITHERAPY
V.3. CLINICAL APIPROPHYLAXIS
Chapter VI. - NOT TRANSLATED
VI.1. - Not translated
VI.1.1 - Not translated
VI.1.2 - Not translated
VI.1.2.1. - Not translated
VI.1.2.2. - Not translated
VI.1.2.3. - Not translated
VI.1.2.4. - Not translated
VI.1.2.5. - Not translated
VI.1.2.6. - Not translated
VI.2. - Not translated
Chapter VII. - The Laboratory Tests
VII.1. THE LABORATORY TESTS. SERUM PROTEIN ELECTROPHORESIS, IONIZED CALCIUM AND REBALANCING PLASMA PROTEINS
VII.1.2. ROUTINE LABORATORY TESTS
VII.1.3 SPECIALIST LABORATORY TESTS
VII.2. THE PROTEINS AND THE HOMEOSTASIS
VII.2.1. PROTEINAEMIA, TOTAL PROTEINS AND DYSPROTEINAEMIA.
VII.2.2. THE TOTAL PROTEINS VALUES CONSIDERED TO BE NORMAL AND VALUES THAT WE PROPOSE TO BE ADOPTED AS NORMAL
VII.3. THE SERUM PROTEIN ELECTROPHORESIS AND IONIZED CALCIUM, VALUABLE TESTS FOR HEALTH
VII.3.1. ILLUSTRATIVE CLINICAL CASES FOR ESTABLISHING THE LIMITS OF THE NORMAL VALUES OF TOTAL AND SERUM PROTEINS
Uterine fibroma, autoimmune disease 35 years old/ 1,56m/ 44 kg
Polycystic ovary 18 years old/ 1,60 m/ 46 kg
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Not translated
Glioblastoma multiforme Standard therapy and apitherapy Apitherapy clinical breakthrough
Copyright ©2010 - 2017 Apitherapy. Toate drepturile Rezervate. | Site realizat de servicii.IT